Clinical trial
A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor
NCT03791112 is registered in ClinicalTrials.gov with Betta Pharmaceuticals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor
- Lead sponsor
- Betta Pharmaceuticals Co., Ltd.
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- July 18, 2019
- Completion date
- December 31, 2025
- Enrollment
- 54 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced solid cancer